ELIZABETH GREEN: Open Payments
NPI 1093715443 · ORANGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 18 payments from 9 companies in 2025. Trend: 2023 $171 · 2024 $299 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $230 |
| Novo Nordisk Inc | 3 | $51 |
| Lilly USA, LLC | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| ABBVIE INC. | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $18 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, Rybelsus, FARXIGA, Qelbree, ZEPBOUND, GEMTESA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
